Cargando…

MicroRNA-137 Inhibits Cancer Progression by Targeting Del-1 in Triple-Negative Breast Cancer Cells

MicroRNAs (miRNAs) can be used to target a variety of human malignancy by targeting their oncogenes or tumor suppressor genes. The developmental endothelial locus-1 (Del-1) might be under miRNA regulation. This study investigated microRNA-137 (miR-137) function and Del-1 expression in triple-negativ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Soo Jung, Jeong, Jae-Hwan, Kang, Seung Hee, Kang, Jieun, Kim, Eun Ae, Lee, Jeeyeon, Jung, Jin Hyang, Park, Ho Yong, Chae, Yee Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941134/ https://www.ncbi.nlm.nih.gov/pubmed/31817673 http://dx.doi.org/10.3390/ijms20246162

Ejemplares similares

MicroRNA-496 inhibits triple negative breast cancer cell proliferation by targeting Del-1
por: Lee, Soo Jung, et al.
Publicado: (2021)

Utility of (18)F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapy
por: Lee, In Hee, et al.
Publicado: (2020)

SAT-137 The Effect of Hypertriglyceridemia on Triple Negative Breast Cancer Progression
por: Scully, Tiffany, et al.
Publicado: (2020)

Impressive effect of cisplatin monotherapy on a patient with heavily pretreated triple-negative breast cancer with poor performance
por: Baek, Dong Won, et al.
Publicado: (2020)

Short-term serial assessment of electronic patient-reported outcome for depression and anxiety in breast Cancer
por: Lee, Jeeyeon, et al.
Publicado: (2021)

Local and regional recurrence following mastectomy in breast cancer patients with 1–3 positive nodes: implications for postmastectomy radiotherapy volume
por: Park, Shin-Hyung, et al.
Publicado: (2018)

MicroRNAs and Triple Negative Breast Cancer
por: D’Ippolito, Elvira, et al.
Publicado: (2013)

Efficacy of an RNA-based multigene assay with core needle biopsy samples for risk evaluation in hormone-positive early breast cancer
por: Lee, Jeeyeon, et al.
Publicado: (2019)

Higher Pathological Complete Response Rate of Less than 10 Total Axillary Lymph Nodes After Axillary Lymph Node Dissection Following Neoadjuvant Chemotherapy in Breast Cancer
por: Lee, Jeeyeon, et al.
Publicado: (2022)

Tumor suppressive microRNA-137 negatively regulates Musashi-1 and colorectal cancer progression
por: Smith, Amber R., et al.
Publicado: (2015)

Evaluation of a Direct Reverse Transcription Loop-Mediated Isothermal Amplification Method without RNA Extraction (Direct RT-LAMP) for the Detection of Lymph Node Metastasis in Early Breast Cancer
por: Lee, In Hee, et al.
Publicado: (2022)

Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer
por: Kim, Ji-Yeon, et al.
Publicado: (2023)

MicroRNA‑606 inhibits the growth and metastasis of triple‑negative breast cancer by targeting Stanniocalcin 1
por: Choi, Sujin, et al.
Publicado: (2023)

Oncologic necessity for the complete removal of residual microcalcifications after neoadjuvant chemotherapy for breast cancer
por: Lee, Jeeyeon, et al.
Publicado: (2022)

Differences in clinical outcomes between HER2-negative and HER2-positive luminal B breast cancer
por: Kang, Byeongju, et al.
Publicado: (2023)

Feasibility of targeted cascade genetic testing in the family members of BRCA1/2 gene pathogenic variant/likely pathogenic variant carriers
por: Lee, Jeeyeon, et al.
Publicado: (2022)

MicroRNAs in regulation of triple-negative breast cancer progression
por: Piasecka, Dominika, et al.
Publicado: (2018)

Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing
por: Chang, Yao-Yin, et al.
Publicado: (2015)

Ultrasound-guided dual-localization for axillary nodes before and after neoadjuvant chemotherapy with clip and activated charcoal in breast cancer patients: a feasibility study
por: Kim, Won Hwa, et al.
Publicado: (2019)

Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51
por: Lee, Jung Ok, et al.
Publicado: (2019)

Differences in prognosis by p53 expression after neoadjuvant chemotherapy in triple-negative breast cancer
por: Bae, Soo Youn, et al.
Publicado: (2020)

Current Treatment Landscape for Early Triple-Negative Breast Cancer (TNBC)
por: Lee, Jieun
Publicado: (2023)

Comparative Study Between Radioisotope Uptake and Fluorescence Intensity of Indocyanine Green for Sentinel Lymph Node Biopsy in Breast Cancer
por: Kang, Byeongju, et al.
Publicado: (2022)

TRIM25 contributes to the malignancy of acute myeloid leukemia and is negatively regulated by microRNA-137
por: Wang, Sheng, et al.
Publicado: (2020)

Bioinformatics identification of dysregulated microRNAs in triple negative breast cancer based on microRNA expression profiling
por: Chen, Junqing, et al.
Publicado: (2018)

Dysregulation of MicroRNA-196b-5p and MicroRNA-375 in Gastric Cancer
por: Lee, Seung Woo, et al.
Publicado: (2016)

MicroRNAs Expression in Triple Negative vs Non Triple Negative Breast Cancer in Tunisia: Interaction with Clinical Outcome
por: Medimegh, Imen, et al.
Publicado: (2014)

Mutations of the Epidermal Growth Factor Receptor Gene in Triple-Negative Breast Cancer
por: Kim, Aeri, et al.
Publicado: (2017)

Tumor suppressor role of microRNA-1296 in triple-negative breast cancer
por: Phan, Binh, et al.
Publicado: (2016)

MicroRNA‐493 is a prognostic factor in triple‐negative breast cancer
por: Yao, Ling, et al.
Publicado: (2018)

Circulating microRNAs and their role in the immune response in triple-negative breast cancer
por: Piña-Sánchez, Patricia, et al.
Publicado: (2020)

Three-dimensional radiomics of triple-negative breast cancer: Prediction of systemic recurrence
por: Koh, Jieun, et al.
Publicado: (2020)

microRNA-137 promotes apoptosis in ovarian cancer cells via the regulation of XIAP
por: Li, Xiaodi, et al.
Publicado: (2017)

In vivo validation of metastasis-regulating microRNA-766 in human triple-negative breast cancer cells
por: Oh, Keunhee, et al.
Publicado: (2017)

Variants of cancer susceptibility genes in Korean BRCA1/2 mutation-negative patients with high risk for hereditary breast cancer
por: Park, Ji Soo, et al.
Publicado: (2018)

Prognostic role of microRNA 182 and microRNA 18a in locally advanced triple negative breast cancer
por: Bajaj, Rajat, et al.
Publicado: (2020)

GPR110 promotes progression and metastasis of triple-negative breast cancer
por: Nam, Hye-Jung, et al.
Publicado: (2022)

Peritumoral edema in breast cancer at preoperative MRI: an interpretative study with histopathological review toward understanding tumor microenvironment
por: Park, Nora Jee-Young, et al.
Publicado: (2021)

MicroRNA 196B regulates FAS-mediated apoptosis in colorectal cancer cells
por: Mo, Ji-Su, et al.
Publicado: (2014)

Fibronectin on circulating extracellular vesicles as a liquid biopsy to detect breast cancer
por: Moon, Pyong-Gon, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0ceiqnsn6328tdbu9upu8eka4m